The trajectory of companies tied to flagship drugs like Viagra presents a challenging investment picture. While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial https://adamnmdv194962.activosblog.com/39787503/sildenafil-and-its-maker-and-the-pharmaceutical-sector-a-dangerous-investment